Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Breast Cancer × abemaciclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 25 Endometrial Neoplasms 6 Neoplasms 5 Neoplasm Metastasis 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Prostatic Neoplasms 3 Head and Neck Neoplasms 3 Glioblastoma 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Pancreatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Brain Neoplasms 2 Urologic Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Retinoblastoma 1 Recurrence 1 Pathologic Complete Response 1 Osteosarcoma 1 Oligodendroglioma 1 Neoplasms, Squamous Cell 1 Neoplasm, Residual 1 Multiple Myeloma 1 Metastatic Castration-Resistant Prostate Cancer 1 Mesothelioma, Malignant 1 Meningioma 1

Interventions

Fulvestrant 7 olaparib 4 Capecitabine 4 pyrotinib 3 Docetaxel 3 Vinorelbine 2 Trastuzumab 2 Alpelisib 2 vandetanib 1 trastuzumab deruxtecan 1 talazoparib 1 sacituzumab govitecan 1 neratinib 1 liposomal doxorubicin 1 exemestane 1 eribulin 1 dalpiciclib 1 ceralasertib 1 cediranib 1 capivasertib 1 abemaciclib 1 Tablets 1 Moxifloxacin 1 Letrozole 1 Goserelin 1 Everolimus 1 Dasatinib 1 Cyclophosphamide 1 Cisplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04227327 2025-07-29

HERMIONE-7

University of Milano Bicocca

Phase 2 Terminated

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡